Journal article
The Feasibility of Quality Assurance in the TOPGEAR International Phase 3 Clinical Trial of Neoadjuvant Chemoradiation Therapy for Gastric Cancer (an Intergroup Trial of the AGITG/TROG/NHMRC CTC/EORTC/CCTG)
J Lukovic, AJ Moore, MT Lee, D Willis, S Ahmed, M Akra, E Hortobagyi, T Kron, D Lim Joon, A Liu, J Ryan, M Thomas, K Wall, I Ward, KL Wiltshire, CJ O'Callaghan, RKS Wong, JG Ringash, K Haustermans, T Leong
International Journal of Radiation Oncology Biology Physics | ELSEVIER SCIENCE INC | Published : 2023
Abstract
Purpose: The TOPGEAR phase 3 trial hypothesized that adding preoperative chemoradiation therapy (CRT) to perioperative chemotherapy will improve survival in patients with gastric cancer. Owing to the complexity of gastric irradiation, a comprehensive radiation therapy quality assurance (RTQA) program was implemented. Our objective is to describe the RTQA methods and outcomes. Methods and Materials: RTQA was undertaken in real time before treatment for the first 5 patients randomized to CRT from each center. Once acceptable quality was achieved, RTQA was completed for one-third of subsequent cases. RTQA consisted of evaluating (1) clinical target volume and organ-at-risk contouring and (2) ra..
View full abstractRelated Projects (2)
Grants
Awarded by Canadian Cancer Society Research Institute
Funding Acknowledgements
This research has been supported by the National Health and Medical Research Council (1046425 and 2000711) , Canadian Institutes of Health Research (grant no. 119445) , Canadian Cancer Society Research Institute (grant no. 021039) , Health Research Council of New Zealand International Investment Opportunities Fund (contract no. 09/624) , European Organisation for Research and Treatment of Cancer Research Fund, and Cancer Australia Priority-driven Collaborative Research Scheme (project ID 570996) .